Results 121 to 130 of about 659,528 (297)

Populations Addressed in Vaccines Approved via the European Medicines Agency

Clinical Pharmacology &Therapeutics, Volume 118, Issue 2, Page 459-469, August 2025.
Therapeutic and prophylactic agents require robust evidence before patient use. Randomized controlled trials are essential for evaluating safety and efficacy but often exclude specific populations that are also targets for the intervention. This study assessed which populations are included in vaccine registration studies and/or addressed in label ...
Débora D. Gräf, Lukas Westphal, Jonathan Kimmelman, Christine E. Hallgreen   +3 more
wiley   +1 more source

Insight Into Resistance Phenotypes of Emergent Non 13-valent Pneumococcal Conjugate Vaccine Type Pneumococci Isolated From Invasive Disease After 13-valent Pneumococcal Conjugate Vaccine Implementation in France

Open Forum Infectious Diseases, 2016
Implementation of 13-valent conjugate pneumococcal vaccine in France has led to an overall antibiotic resistance decrease among invasive pneumococcal isolates.
C. Janoir, A. Lepoutre, L. Gutmann, E. Varon   +3 more
semanticscholar   +1 more source

Influenza Vaccination and Short‐Term Risk of Stroke Among Elderly Patients With Chronic Comorbidities in a Population‐Based Cohort Study

The Journal of Clinical Hypertension, Volume 27, Issue 8, August 2025.
ABSTRACT The protective effect of influenza vaccination on stroke risk has been inconclusive. In this study, we aimed to investigate the impact of influenza vaccination on the 1‐year risk of stroke in individuals aged 60 years and older with COPD and hypertension or diabetes mellitus.
Yuheng Wang, Wenli Xu, Chenyang Jin, Siyuan Wang, Qinghua Yan, Fei Wu, Zhuoying Huang, Kangpei Yu, Minna Cheng, Yan Shi   +9 more
wiley   +1 more source

The Nurse Practitioner's Immuniser Role in Primary Healthcare: A Scoping Review

Journal of Clinical Nursing, Volume 34, Issue 8, Page 3072-3084, August 2025.
ABSTRACT Aim(s) This scoping review aimed to explore and identify literature about the scope of practice for nurse practitioners working as immunisers in primary healthcare. Design The review was conducted according to the JBI scoping review framework.
Christine Schoenfisch, Kate Kauter, Leah East   +2 more
wiley   +1 more source

The Hajj 2019 Vaccine Requirements and Possible New Challenges [PDF]

, 2019
Each year millions of pilgrims perform the annual Hajj from more than 180 countries around the world. This is one of the largest mass gathering events and may result in the occurrence and spread of infectious diseases.
Al-Tawfiq, Jaffar A., Memish, Ziad A.
core   +1 more source

Prevention of Antibiotic-Nonsusceptible Invasive Pneumococcal Disease With the 13-Valent Pneumococcal Conjugate Vaccine.

Clinical Infectious Diseases, 2016
BACKGROUND Antibiotic-nonsusceptible invasive pneumococcal disease (IPD) decreased substantially after the US introduction of the pediatric 7-valent pneumococcal conjugate vaccine (PCV7) in 2000.
S. Tomczyk, R. Lynfield, W. Schaffner, A. Reingold, L. Miller, S. Petit, C. Holtzman, S. Zansky, A. Thomas, Joan Baumbach, L. Harrison, M. Farley, B. Beall, L. McGee, R. Gierke, Tracy Pondo, L. Kim   +16 more
semanticscholar   +1 more source

Pneumococcic Vaccine In Pneumonia [PDF]

The American Journal of the Medical Sciences, 1909
n ...
openaire   +1 more source

Rapid replacement by non-vaccine pneumococcal serotypes may mitigate the impact of the pneumococcal conjugate vaccine on nasopharyngeal bacterial ecology

Scientific Reports, 2017
There is growing concern that interventions that alter microbial ecology can adversely affect health. We characterised the impact of the seven-valent pneumococcal conjugate vaccine (PCV7) on pneumococcal carriage and the bacterial component of the ...
B. Kwambana-Adams, B. Hanson, A. Worwui, S. Agbla, E. Foster-Nyarko, Fatima Ceesay, Chinelo Ebruke, U. Egere, Yanjiao Zhou, Maze Ndukum, E. Sodergren, M. Barer, R. Adegbola, G. Weinstock, M. Antonio   +14 more
semanticscholar   +1 more source

Pneumococcal pneumonia and carriage in Africa before and after introduction of pneumococcal conjugate vaccines, 2000–2019: protocol for systematic review

BMJ Open, 2019
Introduction Africa harbours a high burden of pneumococcal disease, with associated high mortality rates. Despite 34 countries introducing the pneumococcal conjugate vaccine, which reduces the risk of pneumococcal carriage (a prerequisite for disease) of
Neil French, Dean Everett, Newton L. Kalata, Tinashe K. Nyazika, Todd D. Swarthout, Robert S. Heyderman, Stephen B. Gordon, Kondwani C. Jambo   +7 more
doaj   +1 more source

Use and efficacy of pneumococcal vaccine in patients with Hodgkin disease [PDF]

, 1979
AM Levine, GD Overturf, RF Field, D Holdorf, A Paganini-Hill, DI Feinstein   +5 more
openalex   +1 more source